Steatohepatitis in obese individuals

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 16, Issue 5, 2002, Pages 733-747

  Youssef, Wael I ^a   McCullough, Arthur J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Diabetes mellitus; Insulin resistance syndrome; Non alcoholic fatty liver (NAFL); Non alcoholic steatohepatitis (NASH); Obesity; Prevalence; Treatment

Indexed keywords

ALPHA TOCOPHEROL; BETAINE; CLOFIBRATE; GEMFIBROZIL; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; ROSIGLITAZONE; TROGLITAZONE; URSODEOXYCHOLIC ACID;

ADIPOCYTE; ALCOHOL CONSUMPTION; BARIATRIC SURGERY; BODY WEIGHT; BODY WEIGHT DISORDER; COMORBIDITY; DEATH; DEVELOPED COUNTRY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; FATTY LIVER; HEPATITIS; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTION; PREVALENCE; REVIEW; RISK FACTOR; TREATMENT INDICATION; WEIGHT REDUCTION; DIABETES MELLITUS; DRUG MECHANISM; GLUCOSE METABOLISM; HEPATOMEGALY; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER CELL CARCINOMA; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROGNOSIS; ROUX Y ANASTOMOSIS; CHRONIC DISEASE;

CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FATTY LIVER; HUMANS; OBESITY; PREVALENCE; RISK FACTORS;

EID: 0036782036     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2002.0334     Document Type: Article

References (141)

1. Yanovski S Yanovski J A Obesity New England Journal of Medicine 346 2002 591-602
2. Seidell J C Obesity, insulin resistance and diabetes - a worldwide epidemic British Journal of Nutrition 83 2000 55-58 (supplement 1)
3. Uauy R Albala C Kain J Obesity trends in Latin America: transiting from under- to overweight Journal of Nutrition 131 2002 8935-8995
4. Flegal K M Trends in body weight and overweight in the U.S. population Nutritional Reviews 54 1996 S97-S100
5. Kuczmarski R J Carroll M D Flegal K M Troiano R P Varying body mass index cut-off points to describe overweight prevalence among U.S. adults. NHANES III (1988-1994) Obesity Research 5 1997 542-558
6. From the Centers for Disease Control and Prevention: Update. Prevalence of overweight among children, adolescents, and adults. Archives of Pediatrics and Adolescent Medicine 149 1995 1085-1091
7. Kopelman P G Obesity as a medical problem Nature 404 2000 635-643
8. Npgicjo T Tanaka T Insulin resistance and its molecular control Obesity Research 3 1995 195S-198S (supplement 2)
9. Burke J P Williams K Gaskill S P et al. Rapid rise in the incidence of type 2 diabetes from 1987-1996; results from the San Antonio Heart Study Archives of Internal Medicine 159 1999 1450-1456
10. Harris M I Flegal K M Vowie C C et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey; 1988-1994 Diabetes Care 21 1998 518-524
11. King H Aubert R E Herman W H Global burden of diabetes 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414-1431
12. Anderson T Gluud C Liver morphology in morbid obesity: a literature study International Journal of Obesity 8 1984 97-106
13. Nasrallah S M Wills C E Galambos J T Hepatic morphology in obesity Digestive Diseases and Sciences 26 1981 325-327
14. Kern W H Heger A H Payne J H et al. Fatty metamorphosis of the liver in morbid obesity Archives of Pathology 96 1973 342-346
15. Klain J Fraser D Goldstein J et al. Liver histology abnormalities in the morbidly obese Hepatology 10 1999 873-876
16. Braillon A Capron J P Herve M A et al. Liver in obesity Gut 26 1985 133-139
17. Nomura F Ohnishi K Satomura Y et al. Liver function on moderate obesity - study in 534 moderately obese subjects among 4613 male company employees International Journal of Obesity 10 1986 349-354
18. Ratziu V Giral P Charlotte F et al. Liver fibrosis in overweight patients Gastroenterology 118 2000 1117-1123
19. Angulo P Keach J C Batts K P et al. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis Hepatology 30 1999 1356-1362
20. Wanless I R Bargman J Oreopoulos D G et al. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity Modern Pathology 2 1989 69-74
21. Marchesini G Brizi M Morselli-Labate A M et al. Association of nonalcoholic fatty liver disease with insulin resistance American Journal of Medicine 107 1999 450-455
22. Marceau P Biron S Hould F S et al. Liver pathology and the metabolic syndrome X in severe obesity Journal of Clinical Endocrinology and Metabolism 84 1999 1513-1517
23. Sanyal A J Campbell-Sargent C Mirshani K et al. Nonalcoholic steatohepatitis: association of insulin resistance Gastroenterology 120 2001 1183-1192
24. Marchesini G Brizi M Bianchi G et al. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome Diabetes 50 2001 1-7
25. Naveau S Giraud V Borott E et al. Excess weight as a risk factor for alcoholic liver disease Hepatology 25 1997 108-111
26. McCullough A J Falck-Ytter Y Body composition and hepatic steatosis as precursors for fibrotic liver disease Hepatology 29 1999 1328-1330
27. Fong D G Nehra V Lindor K Buchman A L Metabolic and nutritional considerations in nonalcoholic fatty liver Hepatology 32 2000 3-10
28. Falck-Ytter Y Younossi Z M Marchesini G McCullough A J Clinical features and natural history of non-alcoholic steatosis syndromes Seminars in Liver Disease 21 2001 17-26
29. Adler M Schaffner F Fatty liver hepatitis and cirrhosis in obese patients American Journal of Medicine 67 1979 811-816
30. Angulo P Non-alcoholic fatty liver disease New England Journal of Medicine 346 2002 1221-1231
31. Ludwig J Viggiano T R McGill D B Ott B J Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hither to unnamed disease Mayo Clinic Proceedings 55 1980 434-438
32. Lee R G Non-alcoholic steatohepatitis: A study of 49 patients Human Pathology 20 1989 594-598
33. Powell E E Cookesley E GE Hanson R et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74-80
34. Matteoni C A Younossi Z M Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413-1419
35. Younossi Z M Gramlich T Liu Y C et al. Non-alcoholic fatty liver disease: assessment of variability in pathologic interpretations Modern Pathology 11 1998 560-565
36. Lee R G Non alcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler Hepatology 21 1995 1742-1747
37. Das U N Is obesity an inflammatory condition Nutrition 17 2001 953-966
38. Shuldiner A R Yang R Gong D W Resistin, obesity, and insulin resistance - the emerging role of the adipocyte as an endocrine organ New England Journal of Medicine 345 2001 1345-1346
39. Diehl A M Goodman Z Ishak K G Alcohol-like liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury Gastroenterology 95 1988 1056-1062
40. Bacon B R Farahvash M J Janney C G Neuschwander-Tetri B A Nonalcoholic steatohepatitis: an expanded clinical entity Gastroenterology 107 1994 1103-1109
41. Pinto H C Baptista A Camilo M E et al. Non-alcoholic steatohepatitis clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients Digestive Diseases and Sciences 41 1996 172-179
42. Laurin J Lindor K D Cripin J S et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcoholic steatohepatitis - a pilot study Hepatology 23 1996 1464-1467
43. Baldridge A D Perez-Atayde A R Graeme-Cook F Higgins L Lavine J E Idiopathic steatohepatitis in childhood: a multicenter retrospective study Journal of Pediatrics 127 1995 700-704
44. Rashid M Roberts E A Nonalcoholic steatohepatitis in children Journal of Pediatric Gastroenterology and Nutrition 30 2000 48-52
45. George D K Goldwurm S MacDonald G A et al. Increased hepatic iron concentration in non-alcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311-318
46. Strauss R S Pollack H A Epidemic increase in childhood overweight, 1986-1998 Journal of American Medical Association 286 2001 2845-2848
47. Sinha R Fisch G Teague B et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity New England Journal of Medicine 346 2002 802-810
48. Rosenbloom A L Young R S Joe J R et al. Emerging epidemic of type 2 diabetes in youth Diabetes Care 22 1999 345-354
49. Day C P James O F Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463-1466
50. Day C P James O FW Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842-845
51. Pessayre D Berson A Fromenty B et al. Mitochondria in steatohepatitis Seminars in Liver Disease 21 2001 57-69
52. Parola M Pinzani M Casini A et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen α1 (1) gene expression in human liver fat-storing cells Biochemical and Biophysical Research Communications 194 1993 1044-1050
53. Lee K S Buck M Houghlum K et al. Activation of hepatic stellate cells by TGF α and collagen type 1 is mediated by oxidative stress throughc-myo expression Journal of Clinical Invesigation 96 1995 2461-2468
54. Bedossa P Houghlum K Trautwein C et al. Stimulation of collagen alpha 1 (1) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis Hepatology 19 1994 1262-1271
55. Hinsworth H P Diet and the incidence of diabetes mellitus Clinical Sciences 2 1935 117-148
56. Kawate R Yanakido M Nishimoto Y et al. Diabetes mellitus and its vascular complications in Japanese migrants on the island of Hawaii Diabetes Care 2 1979 161-170
57. Pratley R E Gene - environment interactions in the pathogenesis of type 2 diabetes mellitus, lessons learned from the Pima Indians Proceedings of the Nutrition Society 57 1998 175-181
58. Van Dam R M Rimm E Willett W C et al. Dietary patterns and risk for type 2 diabetes mellitus in US men Annals of Internal Medicine 136 2002 201-209
59. James O F Day C P Non-alcoholic steatohepatitis: another disease of affluence Lancet 353 1999 1634-1636
60. Ahima R S Flier J S Adipose tissue as an endocrine organ Trends in Endocrinology and Metabolism 11 2000 327-332
61. Steppan C M Bailey S T Bhat S et al. The hormone resistin links obesity to diabetes Nature 409 2001 307-312
62. Katsuki A Sumida Y Murashima S et al. Serum levels of tumor necrosis factor α are increased in obese patients with non-insulin-dependent diabetes mellitus Journal of Clinical Endocrinology and Metabolism 83 1998 859-862
63. Hotamisligil G S Peraldi P Budavaria D et al. IRS-1 mediated inhibition of insulin receptor kinase activity in INF-alpha and obesity-induced insulin resistance Science 271 1996 665-668
64. Kim K H Lee K Moon Y S et al. A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation Journal of Biological Chemistry 276 2001 11252-11256
65. Lonnquist F Arner P Nordfors L et al. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects Nature Medicine 1 1995 950-953
66. Bergman R N Ader M Free fatty acids and pathogenesis of type 2 diabetes mellitus Trends in Endocrinology and Metabolism 11 2000 351-356
67. Nadler S T Attie A D Please pass the chips: genomic insights into obesity and diabetes Journal of Nutrition 131 2001 2078-2081
68. Pagano G Pacini G Musso G et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association Hepatology 35 2002 357-372
69. Chitturi S Abeygunasekera S Farrell G C et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome Hepatology 35 2002 373-379
70. Comert B Mas M R Erdem H et al. Insulin resistance in non-alcoholic steatohepatitis Digestion and Liver Disease 33 2002 353-358
71. Knobler H Schatner A Zhornicki T et al. Fatty liver - an additional and treatable feature of the insulin resistance syndrome Quarterly Journal of Medicine 92 1999 73-79
72. Kral J G Schaffner F Pierson R N Wang J Body fat topography as an independent prediction of fatty liver Metabolism 42 1993 548-551
73. Banerji M A Buckley M C Chaiken R L et al. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin resistant black men with NIDDM International Journal of Obesity and Related Metabolic Disorders 19 1995 846-850
74. Tominga K Kurara J H Chen Y K et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey Digestive Diseases and Sciences 40 1995 2002-2009
75. Peiris A N Mueller R A Smith G A et al. Splanchnic insulin metabolism in obesity. Influence of body for distribution Journal of Clinical Investigation 78 1986 1648-1657
76. Meek S E Nair K S Jensen M D Insulin regulation of regional free fatty acid metabolism Diabetes 48 1999 10-14
77. Barzilai N Banerjee S Hawkins M et al. Calorie restriction reverses hepatic insulin resistance in aging by decreasing visceral fat Journal of Clinical Investigation 101 1998 1353-1361
78. Barzilai N She L Liu B Q et al. Surgical removal of visceral fat reverses hepatic insulin resistance Diabetes 48 1999 94-98
79. Marchesini G Forlani G NASH: from liver disease to metabolic disorders and back to clinical hepatology Hepatology 35 2002 497-499
80. Hilden M Christoffersen P Juhl E et al. Liver histology in a "normal" population - examinations of 503 consecutive fatal traffic casualties Scandinavian Journal of Gastroenterology 12 1977 593-597
81. Ground K E Liver pathology in aircrew Aviation, Space, and Environmental Medicine 53 1982 14-18
82. Lonardo A Bellini M Taroni P et al. The bright liver syndrome: prevalence and determination of a "bright" liver echo pattern Italian Journal of Gastroenterology and Hepatology 29 1997 351-356
83. Nomura H Kashiwagi S Hayashi J et al. Prevalence of fatty liver in a general population of Okinawa, Japan Japanese Journal of Medicine 27 1988 142-149
84. Ballentni S Saccoccio G Masutti F et al. Prevalence of and risk factors for hepatic steatosis in northern Italy Annals of Internal Medicine 132 2000 112-117
85. Byron D Minuk G Y Clinical hepatology: profile of an urban, hospital-based practice Hepatology 24 1996 813-815
86. Danie S Ben-Manachem T Vasudevan G et al. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients American Journal of Gastroenterology 94 1999 3010-3014
87. Dixon J B Bhathal P S O'Brien P E Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 2001 91-100
88. Wanlesss I R Lentz J S Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Gastroenterology 12 1999 1106-1110
89. Mokdad A H Serdula M K Dietz W H et al. The spread of the obesity epidemic in the United States, 1991-1998 Journal of the American Medical Association 282 1999 1519-1522
90. Mokdad A H Bowman B A Ford E S et al. The continuing epidemics of obesity and diabetes in the United States Journal of the American Medical Association 286 2001 1195-1200
91. Physical Activity and Health: A Report of the Surgeon General 1996 Centers for Disease Control and Prevention Atlanta
92. Harris M L Flegal K M Cowie C C et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: the Third National Health and Nutrition Examination Survey, 1988-1994 Diabetes Care 21 1998 518-524
93. Holbrook T L Barrett-Conor E Wingard D L The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community International Journal of Obesity 13 1989 723-729
94. Chan J M Stampfer M J Rimm E B et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men Diabetes Care 17 1994 961-969
95. Colditz G A Willett W C Rotnitzky A et al. Weight gain as a risk factor for clinical diabetes in women Annals of Internal Medicine 122 1995 481-486
96. Hanson R L Narayan K M McCance D R et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM Diabetes 43 1995 261-262
97. Mokdad A Ford E Bowman B et al. Diabetes trends in the United States, 1990 to 1998 Diabetes Care 23 2000 1278-1283
98. DeMarco R Locatelli F Zoppini G et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study Diabetes Care 22 1999 756-761
99. Kocak N Yuce A Gurakan K Obesity: a cause of steatohepatitis in children American Journal of Gastroenterology 95 2000 1099-1100
100. Teli M R James O F Burt A D The natural history of non-alcoholic fatty liver: a follow-up study Hepatology 22 1994 1714-1719
101. U.S Bureau of the Census. Statistical Abstract of the United States: 1997 1997 117th edn. Washington, DC: US Bureau of the Census
102. Caldwell S H Oelsner D H Iezzoni J et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664-669
103. Poonawala A Nair S Thuluvath P J Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case--control study Hepatology 32 2000 689-692
104. Ong J Younossi Z M Reddy V et al. Cryptogenic cirrhosis and post-transplantation non-alcoholic fatty liver Disease Liver Transplantation 7 2001 797-801
105. Cotrim H P Parana R Braga E et al. Non-alcoholic steatohepatitis and hepato cellular carcinoma: natural history? American Journal of Gastroenterology 95 2000 3018-3019
106. Zen Y Katayanagi K Tsuneyamak K et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathology International 51 2001 127-131
107. El-Serag H B Richardson P A Everhart J E The role of diabetes in hepatocellular carcinoma: a case control study among United States Veterans American Journal of Gastroenterology 96 2001 2462-2467
108. Yang S Lin H Z Hwang J et al. Hepatic hyperplasia in non-cirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Research 61 2001 5016-5023
109. Willner I R Waters B Patil S R et al. Ninety patients with non-alcoholic steatohepatitis: insulin resistance, familial tendency, and severity of obesity American Journal of Gastroenterology 96 2001 2957-2961
110. Silverman J F O'Brien K F Long S et al. Liver pathology in morbidly obese. Patients with and without diabetes American Journal of Gastroenterology 85 1990 1349-1355
111. Younossi Z M Matteoni C A Gramlich T L et al. Diabetes and non-alcoholic fatty liver disease: a worrisome combination Gastroenterology 116 1999 1292
112. Siegelman E S Rosen M A Imaging of hepatic steatosis Seminars in Liver Disease 21 2001 71-80
113. Eriksson S Eriksson K F Bondesson L Non-alcoholic steatohepatitis in obesity: a reversible condition Acta Medica Scandinavia 220 1986 83-88
114. Drenick E J Simmons F Murphy J Effect of hepatitis morphology of treatment of obesity by fasting, reducing diets and small bowel bypass New England Journal of Medicine 282 1970 829-834
115. Palmer M Schaffner F Effect of weight reduction on hepatic abnormalities in overweight patients Gastroenterology 99 1990 1408-1413
116. Ueno T Sugawara H Sujaku K et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver Journal of Hepatology 27 1997 103-107
117. Vajro P Fontanella A Perna C et al. Persistent hyperaminotransferasemia resolving after weight reduction in obese children Journal of Pediatrics 125 1994 239-241
118. Franzese A Vajro P Argenziano A Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population Digestive Diseases and Sciences 42 1997 1428-1432
119. Rashid M Roberts E Nonalcoholic steatohepatitis in children Journal of Pediatric Gastroenterology and Nutrition 30 2000 48-53
120. Rozenthal P Biava C Spencer H Zimmerman H J Liver morphology and function tests in obesity and during total starvation American Journal of Digestive Diseases 12 1967 198-208
121. Anderson T Gluud C Franzmann M B Christoffersen P Hepatic effects of dietary weight loss in morbidly obese patients Hepatology 12 2001 224-229
122. Angulo P Lindor K D Treatment of nonalcoholic fatty liver: present and emerging therapies Seminars in Liver Disease 21 2001 81-88
123. Kanders B S Blackburn G L Very low-calorie diets for the treatment of obesity In Blackburn G L & Kanders B S (eds) Obesity: Pathophysiology, Psychology and Treatment 1994 197-215 Chapman & Hill New York
124. Lin H Z Yang S Q Chuckaree C et al. Metformin reverses fatty liver disease in obese, lept-deficient mice Nature Medicine 6 2000 989-1003
125. Marchesini G Brizi M Bianchi G et al. Metformin in non-alcoholic steatohepatitis Lancet 358 2001 893-894
126. Caldwell S H Hespenheide E E Redick J A et al. A pilot study of a thiazolidinedione, Troglitazone in nonalcoholic steatohepatitis American Journal of Gastroenterology 96 2001 519-525
127. Watkins P B Whitcomb R W Hepatic dysfunction associated with Troglitazone New England Journal of Medicine 338 1998 916-917
128. Al-Salman J Arjomand H Kemp G Mittal M . Hepatocellular injury in a patient receiving Rosiglitazone Annals of Internal Medicine 132 2000 121-124
129. Basaranoglu M Acbay O Sonsuz A A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis Journal of Hepatology 32 1999 384
130. Abdelmalek M F Angulo P Jorgensen R A et al. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study American Journal of Gastroenterology 96 2001 2711-2717
131. Lavine J E Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study Journal of Pediatrics 136 2000 735-738
132. Hasegawa T Yoneda M Nakamura K et al. Plasma transforming growth factor-β1 level and efficacy of α-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study Alimentary Pharmacology and Therapeutics 19 2001 1667-1672
133. Sugerman H J The epidemic of severe obesity: the value of surgical treatment Mayo Clinic Proceedings 75 2000 669-672
134. Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Annals of Internal Medicine 115 1991 956-961
135. Sjostrum C D Lissner L Wedel H et al. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS intervention study Obesity Research 7 1999 477-484
136. Callee E E Thun M J Rodriquez C et al. Body mass index and mortality in a prospective cohort of U.S. adults New England Journal of Medicine 341 1999 1097-1105
137. Balsiger B M Kennedy F P Abu-Lebdeh H S et al. Prospective evaluation of Rous-en-Y gastric bypass as primary operation for medically complicated obesity Mayo Clinic Proceedings 75 2000 673-680
138. Keal J G Surgery for obesity Current Opinion in Gastroenterology 17 2001 154-161
139. Luyckx F H Desaive C Thiry A et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplexy International Journal of Obesity 22 1998 222-226
140. Silverman E Sapala J Appelman H Regression of hepatic steatosis in morbidly obese persons after gastric bypass American Journal of Clinical Pathology 104 1995 23-31
141. Ranlov I Hardt F Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity Digestion 47 1990 208-214